The Keller and Heckman LLP E-Vapor and Tobacco Law Symposium provided in-depth discussions on the...
The FDA’s Authorisation of Zyn: A Robust PMTA in a Changing Landscape
On January 16, 2025, the FDA granted marketing authorisation for Swedish Match’s Zyn nicotine pouches, marking a significant regulatory milestone for the modern oral nicotine market. Given the rapid expansion of this category, many companies may see...
All articles
In the pharmaceutical industry, maintaining smooth laboratory operations is critical to meeting...
The stability of cannabinoid products is a critical factor for manufacturers aiming to deliver...
Nicotine pouches are exciting products that can help support worldwide tobacco harm reduction....
As the global tobacco and nicotine market evolves, nicotine pouches are emerging as a popular...
Broughton welcomes the US Food and Drug Administration’s (FDA) decision to authorize ZYN nicotine...
Navigating FDA and ICH Guidelines: Analytical Testing Validation for Tobacco Products
Oral nicotine pouches have become a disruptive force in the reduced-risk nicotine product...
Allergies concerns highlights need to meet stringent regulations ~
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
